Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FCF1 pseudogene 1 is a DNA sequence in the human genome that closely resembles the FCF1 gene but is not capable of coding for a protein due to mutations or sequence disruptions[5][2]. Pseudogenes like FCF1P1 typically arise from gene duplication or retrotransposition events but have lost their functional protein-coding capacity, though some may retain potential regulatory RNA functionality under specific circumstances[5][2]. FCF1P1 is not considered a therapeutic target and has no known biological function or disease role. There is likely an error or misunderstanding in targeting FCF1P1 as a therapeutic or research target, as it does not encode a functional protein and lacks established roles in human biology or disease. The parent gene FCF1 encodes a ribosome biogenesis factor involved in rRNA processing[1]. Pseudogenes in general can sometimes have regulatory RNA functions, but there is no evidence or established role for FCF1P1 in any disease, biological process, or therapy[2][5]. Due to its status as a pseudogene, FCF1P1 should not be considered a druggable or functional target; any reference to it as such is likely due to confusion with the functional FCF1 gene. FCF1P1 is not a protein, not a functional gene, and not a recognized target for therapeutic intervention; consider verifying the intended target if this gene is referenced in drug discovery or biological research[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FCF1 pseudogene 1 (FCF1P1).